Baxalta Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Baxalta Gmbh

Patent Number:
Title:
Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production
Applicant:
Opposition Date:
Mar 12, 2019
Patent Number:
Title:
Improved Process For The Culturing Of Cells
Opposition Date:
May 30, 2018
Patent Number:
Title:
Protein Purification Method
Opposition Date:
Feb 12, 2018
Patent Number:
Title:
Improved Process For The Culturing Of Cells
Opposition Date:
Dec 21, 2017
Patent Number:
Title:
Improved Process For The Culturing Of Cells
Opposition Date:
Dec 21, 2017

Latest patents of Baxalta Gmbh opposed by its competitors

Patent:
Grant Date:
Mar 15, 2023
Title:
Method Of Producing Recombinant High Molecular Weight Vwf In Cell Culture
Oppositions:
1
Patent:
Grant Date:
Oct 6, 2021
Title:
Substantially Animal Protein-Free Recombinat Furin And Methods For Producing Same
Oppositions:
1
Patent:
Grant Date:
Mar 24, 2021
Title:
Dosage Regimen For Anti-Mif Antibodies
Oppositions:
1
Patent:
Grant Date:
Apr 22, 2020
Title:
Oligopeptide-Free Cell Culture Media
Oppositions:
6
Patent:
Grant Date:
Apr 15, 2020
Title:
Systems And Methods To Increase Protein Yield From Recombinant Manufacturing Processes
Oppositions:
1
Patent:
Grant Date:
May 29, 2019
Title:
Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders
Oppositions:
1
Patent:
Grant Date:
Nov 29, 2017
Title:
Eluate Collection Using Conductivity Gradient
Oppositions:
1
Patent:
Grant Date:
Sep 20, 2017
Title:
Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression
Oppositions:
1
Patent:
Grant Date:
Apr 19, 2017
Title:
Oligopeptide-Free Cell Culture Media
Oppositions:
6

Want to track Baxalta Gmbh?

Feel free to send us a message here and we will get back to you